Molecular remission induced by gemtuzumab ozogamicin associated with donor lymphocyte infusions in t(4;11) acute lymphoblastic leukemia relapsed after transplantation.
Balduzzi
Adriana
A
Rossi
Vincenzo
V
Corral
Lilia
L
Bonanomi
Sonia
S
Longoni
Daniela
D
Rovelli
Attilio
A
Conter
Valentino
V
Biondi
Andrea
A
Uderzo
Cornelio
C
D015703:Antigens, CD / Q000097:blood; D015214:Antigens, Differentiation, Myelomonocytic / Q000097:blood; D002880:Chromosomes, Human, Pair 11; D002894:Chromosomes, Human, Pair 4; D006650:Histocompatibility Testing; D006801:Humans; D017710:Lymphocyte Transfusion; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics* / Q000276:immunology / Q000628:therapy; D012008:Recurrence; D063268:Sialic Acid Binding Ig-like Lectin 3; D033581:Stem Cell Transplantation; D014178:Translocation, Genetic
D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; C571163:CD33 protein, human; D063268:Sialic Acid Binding Ig-like Lectin 3